Articles by Jim Miller - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jim Miller

Building a Turnkey Manufacturing Solution

Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.
Oct 1, 2009

Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.

Waiting for Godot: Will Venture Funding Return?

Contract research, development, and manufacturing organizations betting on a comeback in venture capital financing will have a long wait.
Aug 1, 2009

Contract research, development, and manufacturing organizations betting on a comeback in venture capital financing will have a long wait.

UK Service Providers Look to the New World

UK-based CMOs seek opportunities in new markets.
Jun 1, 2009

UK-based CMOs seek opportunities in new markets.

Declining Market Demand Intensifies Competition

The current competitive environment is forcing service providers to evaluate their business models and focus on value and performance.
May 1, 2009

The current competitive environment is forcing service providers to evaluate their business models and focus on value and performance.

Less Venture Capital Means Less Work for CROs

As financing for early-stage companies gets tighter, small CROs will find fewer new business opportunities
Feb 1, 2009

What the current lack of venture capital means for the CRO market.

Biomanufacturing Capacity Quandary

The outlook for cell culture capacity is highly variable, but contract manufacturing capacity could be tight.
Nov 1, 2008

There could be a serious glut of commercial scale mammalian cell culture capacity over the next five years. Then again, there could be a significant shortage. It all depends on how things develop in expression technology, the new product pipeline, and corporate strategies.

The Art of the Deal

CMOs should recognize that strategic outsourcing relationships must be based on more than just capacity.
Sep 1, 2008

Risk mitigation should be a key aspect of any contract manufacturing organization's business strategy.

Biomanufacturing Pendulum Swings Toward Overcapacity

The biomanufacturing building boom is merging with several industry trends to create a looming overcapacity situation.
May 1, 2008

The current overcapacity situation in the bio/pharmaceutical industry is a reminder that CMOs need to come up with business models and value propositions that are based on more than just selling capacity.

Offshore Opportunity on the Rise

Mar 1, 2008

The supply base for preclinical and clinical development services continues to expand in China.

ADVERTISEMENT

ADVERTISEMENT

Click here